- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
59 Lung Disease Trials Near You
Power is an online platform that helps thousands of Lung Disease patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerNivolumab + Ipilimumab for Rare Cancers
Trial Details
Key Eligibility Criteria
818 Participants Needed
Targeted Therapy for Cancer
Trial Details
Key Eligibility Criteria
6452 Participants Needed
ALIS for Nontuberculous Mycobacterial Infections
Trial Details
Key Eligibility Criteria
425 Participants Needed
RSP-1502 Inhalation for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
72 Participants Needed
AV-001 for COVID-19
Trial Details
Key Eligibility Criteria
120 Participants Needed
BGF with Different Propellants for COPD
Trial Details
Key Eligibility Criteria
297 Participants Needed
Tezepelumab for COPD
Trial Details
Key Eligibility Criteria
990 Participants Needed
Tozorakimab for COPD
Trial Details
Key Eligibility Criteria
1454 Participants Needed
Cold Saline Irrigation for Lung Disease
Trial Details
Key Eligibility Criteria
120 Participants Needed
Itepekimab for COPD
Trial Details
Key Eligibility Criteria
1127 Participants Needed
Sigvotatug Vedotin vs Docetaxel for Lung Cancer
Trial Details
Key Eligibility Criteria
670 Participants Needed
129Xe MRI for Interstitial Lung Disease
Trial Details
Key Eligibility Criteria
147 Participants Needed
Belimumab for Systemic Sclerosis Interstitial Lung Disease
Trial Details
Key Eligibility Criteria
300 Participants Needed
Mosliciguat for Pulmonary Hypertension
Trial Details
Key Eligibility Criteria
120 Participants Needed
Abatacept for Interstitial Lung Disease
Trial Details
Key Eligibility Criteria
38 Participants Needed
Itepekimab for COPD
Trial Details
Key Eligibility Criteria
700 Participants Needed
Telehealth Pulmonary Rehabilitation for COPD
Trial Details
Key Eligibility Criteria
768 Participants Needed
AP01 for Pulmonary Fibrosis
Trial Details
Key Eligibility Criteria
300 Participants Needed
Lung Transplant Education for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
132 Participants Needed
Diuretic Therapy for Bronchopulmonary Dysplasia
Trial Details
Key Eligibility Criteria
30 Participants Needed
Why Other Patients Applied
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
Vimseltinib for Chronic Graft-Versus-Host Disease
Trial Details
Key Eligibility Criteria
36 Participants Needed
Anifrolumab for Systemic Sclerosis
Trial Details
Key Eligibility Criteria
306 Participants Needed
Efzofitimod for Sarcoidosis
Trial Details
Key Eligibility Criteria
268 Participants Needed
IOV-4001 for Melanoma and Lung Cancer
Trial Details
Key Eligibility Criteria
53 Participants Needed
Selpercatinib for Cancer in Children
Trial Details
Key Eligibility Criteria
50 Participants Needed
Molgramostim for Pulmonary Alveolar Proteinosis
Trial Details
Key Eligibility Criteria
5 Participants Needed
LYT-100 (Deupirfenidone) for Idiopathic Pulmonary Fibrosis
Trial Details
Key Eligibility Criteria
240 Participants Needed
Trial Details
Key Eligibility Criteria
272 Participants Needed
NKT3447 for Advanced Cancer
Trial Details
Key Eligibility Criteria
90 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Lung Disease clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Lung Disease clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Lung Disease trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Lung Disease is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Lung Disease medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Lung Disease clinical trials?
Most recently, we added Tezepelumab for COPD, Ibuzatrelvir for Coronavirus and Vimseltinib for Chronic Graft-Versus-Host Disease to the Power online platform.